Description
XENAZINE 25 MG
First action · last action
2015-07-07 · 2015-07-07
Transactions
1
First transaction's obligation
$6,255
Base + all options value (sum of deltas)
$6,255
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797P14A0003
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-07-07+$6,255= $6,255
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-07-07 | +$6,255 | $6,255 | XENAZINE 25 MG |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI F1M3L99R99B3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79726D0172 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24920N0537 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $25,476 | FY2020 |
| 36C24920N0520 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $20,381 | FY2020 |
| 36C24920N0515 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
| 36C24920N0502 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
| 36C24920N0482 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
Other recipients under 6505 from 613-MARTINSBURG (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24516J0483 | SEQIRUS USA INC | 613-MARTINSBURG | $81,770 | FY2016 |
| VA24516J0481 | SEQIRUS USA INC | 613-MARTINSBURG | $81,770 | FY2016 |
| VA24516F0399 | SANOFI VACCINES US INC. | 613-MARTINSBURG | $17,001 | FY2016 |
| VA24515F0669 | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 613-MARTINSBURG | $70,200 | FY2015 |
| VA24514P2123 | PHARMACYCLICS, INC. | 613-MARTINSBURG | $6,107 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24515F2764_3600_VA797P14A0003_3600 · retrieved 2026-09-26.